Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-18-002031
Filing Date
2018-03-14
Accepted
2018-03-13 21:41:17
Documents
118
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K arlz-20171231x10k.htm 10-K 3584614
2 EX-10.37 arlz-20171231ex1037042b9.htm EX-10.37 40185
3 EX-10.38 arlz-20171231ex103867b99.htm EX-10.38 60663
4 EX-21.1 arlz-20171231ex2116158ca.htm EX-21.1 11590
5 EX-23.1 arlz-20171231ex2312103e1.htm EX-23.1 11116
6 EX-31.1 arlz-20171231ex311800458.htm EX-31.1 15374
7 EX-31.2 arlz-20171231ex312975f9a.htm EX-31.2 18995
8 EX-32.1 arlz-20171231ex321699c6d.htm EX-32.1 11017
9 EX-32.2 arlz-20171231ex3228e69c7.htm EX-32.2 11307
10 GRAPHIC arlz20171231x10k001.jpg GRAPHIC 61492
  Complete submission text file 0001558370-18-002031.txt   14035131

Data Files

Seq Description Document Type Size
11 EX-101.INS arlz-20171231.xml EX-101.INS 3201974
12 EX-101.SCH arlz-20171231.xsd EX-101.SCH 85893
13 EX-101.CAL arlz-20171231_cal.xml EX-101.CAL 98352
14 EX-101.DEF arlz-20171231_def.xml EX-101.DEF 401351
15 EX-101.LAB arlz-20171231_lab.xml EX-101.LAB 729819
16 EX-101.PRE arlz-20171231_pre.xml EX-101.PRE 667470
Mailing Address 7100 WEST CREDIT AVENUE, SUITE 101 MISSISSAUGA A6 L5N 0E4
Business Address 7100 WEST CREDIT AVENUE, SUITE 101 MISSISSAUGA A6 L5N 0E4 905-876-1118
Aralez Pharmaceuticals Inc. (Filer) CIK: 0001660719 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37691 | Film No.: 18688219
SIC: 2834 Pharmaceutical Preparations